Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Feb;6(Suppl 1):S18-S21.
doi: 10.21037/tcr.2017.02.01.

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer

Scott T Eblen  1 , Amber Bradley  1
Affiliations
Comment

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer

Scott T Eblen et al. Transl Cancer Res. 2017 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Galluzzi L, Senovilla L, Vitale I, et al. Molecular mechanisms of cisplatin resistance. Oncogene. 2012;31:1869–83. - PubMed
    1. Tan KO, Fu NY, Sukumaran SK, et al. MAP-1 is a mitochondrial effector of Bax. Proc Natl Acad Sci U S A. 2005;102:14623–8. - PMC - PubMed
    1. Matsuura K, Huang NJ, Cocce K, et al. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin. Oncogene. 2016 [Epub ahead of print] - PMC - PubMed
    1. Vos MD, Dallol A, Eckfeld K, et al. The RASSF1A tumor suppressor activates Bax via MOAP-1. J Biol Chem. 2006;281:4557–63. - PubMed
    1. Baksh S, Tommasi S, Fenton S, et al. The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death. Mol Cell. 2005;18:637–50. - PubMed

LinkOut - more resources